Key result
Carvedilol and pitavastatin dose-dependently normalize lipid profiles and oxidative stress in hyperlipidemic rats.
Answers are grounded in this paper and cite their sources.
Aim of the study was designed to investigate the antihyperlipidemic activity of carvedilol and pitavastatin in tyloxapol-induced hyperlipidemia in Wistar rats. The rats were randomly divided into 6 groups. The vehicle control group-I received 2 mL of normal saline for eight days. The pathological control group-II received tyloxapol (400 mg/kg) on 8th day. The treated group-III received 10 mg/kg carvedilol and group-IV received 20 mg/kg carvedilol for eight days and tyloxapol (400 mg/kg) on the 8th day. The group-V received pitavastatin (0.3 mg/kg) for eight days and tyloxapol (400 mg/kg) on the 8th day. The group-VI received carvedilol (20 mg/kg) only for eight days. After eight days of treatment, triglycerides, total cholesterol, high-density lipoprotein, very low-density lipoprotein, thiobarbituric acid reactive substances, and glutathione were estimated in the serum and myocardial tissues along with DNA fragmentation of the liver tissue using gel-electrophoresis. Oral administration of carvedilol to tyloxapol-induced hyperlipidemic rats normalized the changes in the above parameters in a dose dependent manner. Hence, carvedilol with pitavastatin has antihyperlipidemic activity in tyloxapol-induced hyperlipidemia in Wistar rats.
No takes yet. Share an insight, caveat, or question.
Akbar et al. (2023) studied Tyloxapol-induced hyperlipidemia. Carvedilol and pitavastatin vs. Normal saline (2 mL) vehicle control and tyloxapol (400 mg/kg) pathological control was evaluated on Triglycerides, total cholesterol, HDL, VLDL, TBARS, glutathione in serum and myocardial tissues, and liver DNA fragmentation. Oral carvedilol and pitavastatin for 8 days dose-dependently normalized lipid and oxidative stress parameters in tyloxapol-induced hyperlipidemic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: